$SESN Why I am bullish: 1. Novel therapy awaiting approval for last chance patients with NMIBC 2. The sudden and surprising striking of the R/S option from the agenda of the annual meeting 3. Positive feedback from doctors on dosing patients with Vicineum 4. Relatively inexpensive production costs 5. Top line manufacturers selected for production runs 6. CEO confidence of low key advertising methods 7. Combination trial with Imfinzi 8. High demand of BCG due to Coronavirus 9. Low enough float to move share price on less than 10 million volume 10. Company has no debt
  • 11
@DandyD what? Company has no debt? It has total liability of 140million dollars (yahoo finance). Where did you see that it doesn’t have any debt?